Kamada Ltd.'s revenue has grown 12% a year over three years. Revenue growth, 3-year annual rate: +12% (Drug Manufacturers - Specialty & Generic median +12%). Years of annual history on file: 11, FY2015 to FY2025, as filed.

KMDAKamada Ltd.

Healthcare

$7.76+18% 1Y

$7.76

$6.4352 weeks$9.04

Is it growing?

Excellent

Growing: revenue growing +12% year on year, earnings up +35% year on year, and operating margin widening (+2.1 points).

3 good

Revenue trend+12% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Earnings trend+35% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

Margin direction+2.1 points operating

Trailing-twelve-month operating margin, 14.5% now against 12.4% a year earlier.

All from SEC EDGAR, as of Dec 31, 2025.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is KMDA growing?

Kamada Ltd.'s revenue has grown 12% a year over three years.

+12%

Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +12% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue